UVa Health System wins renewal of $6.2 million grant for Crohn's disease research

October 21, 2005

CHARLOTTESVILLE, Va., Oct. 20, 2005-- A federal grant to The Digestive Health Center of Excellence at the University of Virginia Health System to study the cause of Crohn's disease has been renewed for another five years. The $6.2 million grant from the National Institutes of Health (NIH) came after a competitive review process. It will allow UVa to continue groundbreaking work using a mouse model, which closely resembles Crohn's disease in humans.

"This grant recognizes UVa as one of the premier centers for the study of inflammatory bowel disease in the U.S. and worldwide," said Dr. Fabio Cominelli, chief of gastroenterology at the UVa Health System and a leading Crohn's expert. "Our goal is to discover the cause of spontaneous intestinal inflammation in animals and apply this information to patients with the final goal of developing a cure for at least a subgroup of patients with Crohn's disease. I am extremely excited and proud that the NIH has recognized the accomplishments of our team during the last five years and granted us the funds and opportunity to continue our innovative work to discover the cause of this devastating disease."

Crohn's is a chronic, often debilitating, disease characterized by ulcerations and inflammatory lesions throughout the gastrointestinal tract. Symptoms include severe abdominal pain, diarrhea, weight loss, and general malaise. Experts say more than 600,000 people in the U.S., and millions worldwide, suffer from Crohn's. Right now there is no cure; available treatments only relieve symptoms and sometimes have significant side effects.

The NIH grant will fund a multi-disciplinary program involving five different departments at the UVa Health System. Cominelli is the Principal Investigator. He's joined by Marcia McDuffie, PhD, Steven Cohn, MD, Klaus Ley, MD and Theresa Pizarro, PhD.

Cominelli said the grant renewal will help UVa to continue attracting young investigators from around the world to the field of mucosal intestinal immunology. Today, Crohn's disease researchers at UVa are discovering and characterizing new genes for Crohn's. They are also discovering new targets for drugs, such as novel cytokines, the intestinal epithelium, adhesion molecules and defensins. "This grant will allow us to make these discoveries and develop new ways to diagnose the disease in predisposed individuals as well as develop new treatments that will improve the quality of life for our patients," Cominelli said.
Note: Photo of Dr. Cominelli is available for print.

University of Virginia Health System

Related Gastroenterology Articles from Brightsurf:

Digestive symptoms are prominent among COVID-19 patients reveals study in The American Journal of Gastroenterology
The American Journal of Gastroenterology published today a new study that reveals digestive symptoms, including diarrhea, are common in COVID-19 patients.

Baylor Scott & White gastroenterology researchers share key takeaways from DDW 2019
Dr. Stuart J. Spechler among researchers from Baylor Scott & White Research Institute available to provide key takeaways from Digestive Disease Week 2019.

The Lancet Gastroenterology & Hepatology: Colorectal cancer incidence on the rise among young adults in several high-income countries
The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a decline or stabilisation trend in the incidence of colorectal cancers within the overall populations of high-income countries.

The Lancet Gastroenterology & Hepatology and The Lancet Respiratory Medicine: Whole body MRI may help to detect spread of cancers more quickly
Trials with people with newly-diagnosed colorectal and non-small cell lung cancer suggest that whole body MRI could reduce the time it takes to diagnose the stage of cancers.

The Lancet Gastroenterology & Hepatology: Hypnotherapy could help relieve irritable bowel syndrome symptoms
Peer-reviewed / Randomised Controlled Trial / People Gut-directed hypnotherapy delivered by psychologists appears as effective in group or individual sessions, potentially offering a new treatment option for irritable bowel syndrome in primary and secondary care

Low FODMAP diet and IBS recently published by Dove Medical Press
The evidence to date indicates that restriction of FODMAPs is an effective dietary intervention for reducing IBS symptoms.

Gastroenterology Special Issue confirms: You are what you eat
The editors of Gastroenterology, the official journal of the American Gastroenterological Association, are pleased to announce the publication of this year's highly anticipated special 13th issue on food, the immune system and the gastrointestinal tract.

Bariatric surgery can benefit some obese children and teens, reports Journal of Pediatric Gastroenterology and Nutrition
Bariatric surgery -- as a last resort when conservative interventions have failed -- can improve liver disease and other obesity-related health problems in severely obese children and adolescents, according to a position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

What's the current role of liver biopsy in children? Position paper in Journal of Pediatric Gastroenterology and Nutrition
While noninvasive alternatives are increasingly available, liver biopsy still provides essential information in some children with liver disease, according to a new position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

AGA introduces new journal: Cellular and Molecular Gastroenterology and Hepatology
The American Gastroenterological Association is pleased to welcome a new member to its family of journals: Cellular and Molecular Gastroenterology and Hepatology.

Read More: Gastroenterology News and Gastroenterology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.